South Korea authorizes the emergency use of the anti-viral oral drug Paxlovid manufactured by Pfizer for high-risk patients over the age of 12 years, becoming the first drug to be approved for use in the country. (Yonhap News Agency) COVID-19 pandemic in South Korea, COVID-19 drug developmentCOVID-19 pandemic in AsiaCOVID-19 pandemic link embed save